Oneness Biotech Co., Ltd. (4743.TWO)
TWD 62.1
(5.08%)
TWD 62.1
(5.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 122.73 Million TWD | 7.63% |
| 2022 | 114.03 Million TWD | 16.8% |
| 2021 | 97.62 Million TWD | 70.82% |
| 2020 | 57.15 Million TWD | 18.21% |
| 2019 | 48.34 Million TWD | -4.02% |
| 2018 | 50.37 Million TWD | 23.7% |
| 2017 | 40.72 Million TWD | -1.06% |
| 2016 | 41.16 Million TWD | 27.88% |
| 2015 | 32.18 Million TWD | 44.91% |
| 2014 | 22.21 Million TWD | 38.41% |
| 2013 | 16.04 Million TWD | 111.14% |
| 2012 | 7.6 Million TWD | 85.82% |
| 2011 | 4.09 Million TWD | -0.12% |
| 2010 | 4.09 Million TWD | 285.59% |
| 2009 | 1.06 Million TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 121.82 Million TWD | -1.3% |
| 2024 Q2 | 118.58 Million TWD | -2.66% |
| 2023 Q4 | 123.43 Million TWD | -7.57% |
| 2023 FY | 123.43 Million TWD | 8.24% |
| 2023 Q1 | 121.94 Million TWD | 6.94% |
| 2023 Q2 | 121.6 Million TWD | -0.28% |
| 2023 Q3 | 133.53 Million TWD | 9.81% |
| 2022 Q1 | 96.1 Million TWD | -1.56% |
| 2022 Q2 | 96.68 Million TWD | 0.6% |
| 2022 Q3 | 112.44 Million TWD | 16.3% |
| 2022 Q4 | 114.03 Million TWD | 1.41% |
| 2022 FY | 114.03 Million TWD | 16.8% |
| 2021 Q1 | 58.44 Million TWD | 2.26% |
| 2021 FY | 97.62 Million TWD | 70.82% |
| 2021 Q2 | 73.15 Million TWD | 25.17% |
| 2021 Q3 | 83 Million TWD | 13.46% |
| 2021 Q4 | 97.62 Million TWD | 17.62% |
| 2020 Q4 | 57.15 Million TWD | 6.17% |
| 2020 Q1 | 47.42 Million TWD | -1.92% |
| 2020 Q2 | 50.37 Million TWD | 6.22% |
| 2020 Q3 | 53.83 Million TWD | 6.87% |
| 2020 FY | 57.15 Million TWD | 18.21% |
| 2019 Q2 | 50.47 Million TWD | 1.14% |
| 2019 FY | 48.34 Million TWD | -4.02% |
| 2019 Q3 | 49.32 Million TWD | -2.28% |
| 2019 Q1 | 49.9 Million TWD | -0.93% |
| 2019 Q4 | 48.34 Million TWD | -1.98% |
| 2018 Q1 | 40.67 Million TWD | -0.12% |
| 2018 FY | 50.37 Million TWD | 23.7% |
| 2018 Q4 | 50.37 Million TWD | 24.29% |
| 2018 Q3 | 40.53 Million TWD | -6.35% |
| 2018 Q2 | 43.28 Million TWD | 6.41% |
| 2017 Q1 | 41.35 Million TWD | 0.47% |
| 2017 Q3 | 41.05 Million TWD | -0.48% |
| 2017 Q2 | 41.25 Million TWD | -0.25% |
| 2017 Q4 | 40.72 Million TWD | -0.8% |
| 2017 FY | 40.72 Million TWD | -1.06% |
| 2016 FY | 41.16 Million TWD | 27.88% |
| 2016 Q4 | 41.16 Million TWD | 27.83% |
| 2016 Q3 | 32.19 Million TWD | 0.81% |
| 2016 Q2 | 31.94 Million TWD | -0.13% |
| 2016 Q1 | 31.98 Million TWD | -0.63% |
| 2015 Q1 | 22.25 Million TWD | 0.2% |
| 2015 FY | 32.18 Million TWD | 44.91% |
| 2015 Q3 | 20.7 Million TWD | 1.66% |
| 2015 Q4 | 32.18 Million TWD | 55.48% |
| 2015 Q2 | 20.36 Million TWD | -8.5% |
| 2014 Q2 | 16.31 Million TWD | 1.05% |
| 2014 Q1 | 16.14 Million TWD | 0.58% |
| 2014 FY | 22.21 Million TWD | 38.41% |
| 2014 Q4 | 22.21 Million TWD | 8.81% |
| 2014 Q3 | 20.41 Million TWD | 25.15% |
| 2013 FY | 16.04 Million TWD | 111.14% |
| 2013 Q4 | 16.04 Million TWD | 85.13% |
| 2013 Q3 | 8.66 Million TWD | 18.25% |
| 2013 Q2 | 7.33 Million TWD | 8.48% |
| 2013 Q1 | 6.75 Million TWD | -11.09% |
| 2012 Q4 | 7.6 Million TWD | 45.71% |
| 2012 Q1 | 5.52 Million TWD | 35.09% |
| 2012 Q2 | 6.19 Million TWD | 12.05% |
| 2012 FY | 7.6 Million TWD | 85.82% |
| 2012 Q3 | 5.21 Million TWD | -15.75% |
| 2011 Q3 | 4.49 Million TWD | -2.53% |
| 2011 Q4 | 4.09 Million TWD | -9.09% |
| 2011 Q1 | 4.74 Million TWD | 15.8% |
| 2011 Q2 | 4.61 Million TWD | -2.66% |
| 2011 FY | 4.09 Million TWD | -0.12% |
| 2010 FY | 4.09 Million TWD | 285.59% |
| 2010 Q4 | 4.09 Million TWD | 0.0% |
| 2009 FY | 1.06 Million TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 459.97 Million TWD | 73.317% |
| Level Biotechnology Inc. | 88.85 Million TWD | -38.14% |
| Sagittarius Life Science Corp | 31.54 Million TWD | -289.135% |
| NeoCore Technology Co., Ltd. | 66.38 Million TWD | -84.898% |
| GeneReach Biotechnology Corp. | 67.37 Million TWD | -82.173% |
| Genomics BioSci & Tech. Co.,Ltd. | 61.5 Million TWD | -99.543% |
| Visgeneer Inc. | 49.07 Million TWD | -150.111% |
| Sunmax Biotechnology Co., Ltd. | 93.67 Million TWD | -31.031% |
| G&E Herbal Biotechnology Co., Ltd. | 22.9 Million TWD | -435.876% |
| Neith Corporation | 463 Thousand TWD | -26409.071% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -4.78 Million TWD | 2662.894% |
| Enimmune corporation | 15.7 Million TWD | -681.715% |
| TaiRx, Inc. | 11 Thousand TWD | -1115690.909% |
| EirGenix Inc. | 680.63 Million TWD | 81.967% |
| BioLASCO Taiwan Co., Ltd. | 32.52 Million TWD | -277.374% |
| Sunny Pharmtech Inc. | 97.03 Million TWD | -26.482% |
| Advagene Biopharma Co., Ltd. | -91.99 Thousand TWD | 133511.233% |
| BioGend Therapeutics Co., Ltd. | 16.54 Million TWD | -641.837% |
| Feng Chi Biotech Corp. | 19.03 Million TWD | -544.729% |
| Lukas Biomedical Inc. | 36.72 Million TWD | -234.206% |
| RBC Bioscience Corporation | 44.42 Million TWD | -176.292% |
| BiOptic Inc. | 161.07 Million TWD | 23.8% |
| Anti-Microbial Savior BioteQ Co., Ltd | 505 Thousand TWD | -24204.356% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| Great Novel Therapeutics Biotech & Medicals | 6.16 Million TWD | -1892.16% |
| Syngen Biotech Co.,Ltd. | 348.98 Million TWD | 64.83% |
| Mycenax Biotech Inc. | 112.32 Million TWD | -9.269% |
| Medigen Vaccine Biologics Corporation | 383.63 Million TWD | 68.007% |
| Bio Preventive Medicine Corp. | 1.23 Million TWD | -9814.136% |
| TaiMed Biologics Inc. | 1.26 Billion TWD | 90.299% |
| GlycoNex Incorporation | 17.4 Million TWD | -605.263% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.17 Million TWD | -479.741% |
| SynCore Biotechnology Co.,Ltd | 3.12 Million TWD | -3830.099% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BRIM Biotechnology, Inc. | -6.23 Million TWD | 2067.57% |
| VBI | 10.03 Million TWD | -1123.089% |
| CHO Pharma, Inc. | 1.00 TWD | -12273699900.0% |
| NaviFUS Corp. | 6.87 Million TWD | -1685.785% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 12.16 Million TWD | -908.687% |
| Sinew Pharma Inc. | -766 Thousand TWD | 16123.107% |
| Andros Pharmaceuticals Co.,Ltd | 1.08 Million TWD | -11180.974% |
| Greenyn Biotechnology Co., Ltd | 163.13 Million TWD | 24.764% |
| Lumosa Therapeutics Co., Ltd. | 103.91 Million TWD | -18.116% |
| AP Biosciences Inc | - TWD | -Infinity% |
| Medigen Biotechnology Corp. | 546.9 Million TWD | 77.558% |
| 3D Global Biotech Inc. | 3.59 Million TWD | -3314.103% |
| Pharmosa Biopharm Inc. | 21.9 Million TWD | -460.213% |
| Intech Biopharm Corporation | 41.52 Million TWD | -195.574% |
| Eusol Biotech Co.,Ltd. | -8.1 Million TWD | 1614.898% |
| TWi Biotechnology, Inc. | -435 Thousand TWD | 28315.402% |
| Ever Supreme Bio Technology Co., Ltd | 69.08 Million TWD | -77.658% |
| TCI GENE Inc. | 54.84 Million TWD | -123.781% |
| MegaPro Biomedical Co., Ltd | 20.51 Million TWD | -498.425% |
| Senhwa Biosciences, Inc. | - TWD | -Infinity% |
| Taiwan Bio Therapeutics Co., Ltd | 40.96 Million TWD | -199.622% |
| NatureWise Biotech & Medicals Corporation | 82.5 Million TWD | -48.772% |
| PharmaEngine, Inc. | 15.9 Million TWD | -671.882% |
| Savior Lifetec Corporation | 860.04 Million TWD | 85.729% |
| TaiGen Biopharmaceuticals Holdings Limited | 34.15 Million TWD | -259.363% |
| OBI Pharma, Inc. | 25.93 Million TWD | -373.303% |
| Meribank Biotech Co., Ltd | 6.9 Million TWD | -1676.994% |
| Acepodia, Inc. | 39.52 Million TWD | -210.506% |
| Caliway Biopharmaceuticals Co., Ltd. | 1.02 Million TWD | -11897.752% |